SCHEMBL2255462

SCHEMBL2255462

CC(C)CONc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.50
▸ HPGD P15428 3/20 0.50
▸ TSHR P16473 4/20 0.44
▸ ALOX12 P18054 3/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ TDP1 Q9NUW8 2/20 0.43
▸ MAPT P10636 3/20 0.39
▸ LMNA P02545 5/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ XBP1 P17861 1/20 0.39
▸ THRB P10828 1/20 0.38
▸ RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30536022 0.83 MAOA (0.42) ALDH1A1HPGDTSHRALOX12CYP3A4
SCHEMBL8942379 0.83 LMNA (0.52) ALDH1A1HPGDTSHRALOX12CYP3A4
SCHEMBL10582846 0.82 TDP1 (0.39) ALDH1A1HPGDTSHRALOX12CYP3A4
SCHEMBL11455940 0.82 MAPT (0.40) ALDH1A1HPGDTSHRALOX12CYP3A4
SCHEMBL10437694 0.80 MAPT (0.39) ALDH1A1HPGDTSHRALOX12CYP3A4
SCHEMBL27753606 0.79 ALDH1A1 (0.42) ALDH1A1HPGDTSHRALOX12CYP3A4
SCHEMBL7757887 0.79 ALDH1A1 (0.33) ALDH1A1HPGDTSHRCYP3A4ALOX15
SCHEMBL1581900 0.76 GAA (0.39) ALDH1A1HPGDNPSR1TDP1MAPT
SCHEMBL942342 0.75 TSHR (0.41) ALDH1A1HPGDTSHRCYP3A4HSD17B10
SCHEMBL942241 0.75 GAA (0.41) ALDH1A1HPGDHSD17B10MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102911972-B Preparation method of algistatic active substance di-isobutoxyphenyl amine UNIV XIAMEN 2015-01-21 — — CN claimed
CN-102911972-A Preparation method of algistatic active substance di-isobutoxyphenyl amine UNIV XIAMEN 2013-02-06 — — CN claimed
WO-2009143405-A2 SYNTHESIS OF GRAPHENE SHEETS AND NANOPARTICLE COMPOSITES COMPRISING SAME THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2009-11-26 — — WO claimed
CN-118416038-B Application of 2- (2-methylpropyloxy) aniline in preparation of medicines for treating inflammatory diseases 中国海洋大学 2024-11-12 — — CN disclosed
CN-118416038-B Application of 2- (2-methylpropyloxy) aniline in preparation of medicines for treating inflammatory diseases 中国海洋大学 2024-11-12 — — CN disclosed
CN-118416038-A Application of 2- (2-methylpropyloxy) aniline in preparation of medicines for treating inflammatory diseases 中国海洋大学 2024-08-02 — — CN disclosed
CN-118416038-A Application of 2- (2-methylpropyloxy) aniline in preparation of medicines for treating inflammatory diseases 中国海洋大学 2024-08-02 — — CN disclosed
US-9919300-B2 1-hexene production process SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-20 — — US disclosed
EP-2484685-B1 TRANSITION METAL COMPLEX, PREPARATION METHOD FOR SAID TRANSITION METAL COMPLEX, TRIMERIZATION CATALYST, PREPARATION METHOD FOR 1-HEXENE, PREPARATION METHOD FOR ETHYLENE POLYMER, SUBSTITUTED CYCLOPENTADIENE COMPOUND, AND PREPARATION METHOD FOR SAID SUBSTITUTED CYCLOPENTADIENE COMPOUND SUMITOMO CHEMICAL CO (JP) 2017-11-01 — — EP disclosed
US-20170036200-A1 1-HEXENE PRODUCTION PROCESS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-09 — — US disclosed
US-9090527-B2 Method for producing transition metal complex, catalyst for trimerization, method for producing 1-hexene, method for producing substituted cyclopentadiene compound (2) SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-07-28 — — US disclosed
EP-2484685-A1 TRANSITION METAL COMPLEX, PREPARATION METHOD FOR SAID TRANSITION METAL COMPLEX, TRIMERIZATION CATALYST, PREPARATION METHOD FOR 1-HEXENE, PREPARATION METHOD FOR ETHYLENE POLYMER, SUBSTITUTED CYCLOPENTADIENE COMPOUND, AND PREPARATION METHOD FOR SAID SUBSTITUTED CYCLOPENTADIENE COMPOUND Sumitomo Chemical Co., Ltd (JP) 2012-08-08 — — EP disclosed
US-20120184431-A1 TRANSITION METAL COMPLEX, PREPARATION METHOD FOR SAID TRANSITION METAL COMPLEX, TRIMERIZATION CATALYST, PREPARATION METHOD FOR 1-HEXENE, PREPARATION METHOD FOR ETHYLENE POLYMER, SUBSTITUTED CYCLOPENTADIENE COMPOUND, AND PREPARATION METHOD FOR SAID SUBSTITUTED CYCLOPENTADIENE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-19 — — US disclosed
US-20110186789-A1 SYNTHESIS OF GRAPHENE SHEETS AND NANOPARTICLE COMPOSITES COMPRISING SAME THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2011-08-04 — — US disclosed
WO-2009143405-A2 SYNTHESIS OF GRAPHENE SHEETS AND NANOPARTICLE COMPOSITES COMPRISING SAME THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2009-11-26 — — WO disclosed
EP-0963990-B1 PROCESS FOR PRODUCING CYCLOPENTADIENYL METAL SALTS AND PROCESS FOR PRODUCING CYCLOPENTADIENE DERIVATIVES BY UTILIZING THE SAME SUMITOMO CHEMICAL CO (JP) 2004-10-06 — — EP disclosed
US-6197990-B1 REACTING CYCLOPENTADIENE AND METAL HYDRIDE IN PRESENCE OF AMINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-03-06 — — US disclosed
EP-0963990-A1 PROCESS FOR PRODUCING CYCLOPENTADIENYL METAL SALTS AND PROCESS FOR PRODUCING CYCLOPENTADIENE DERIVATIVES BY UTILIZING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-12-15 — — EP disclosed
US-4423247-A AMINOALKYLATION, NONCATALYTIC REACTION BASF AKTIENGESELLSCHAFT (DE) 1983-12-27 — — US disclosed
US-4067903-A Manufacture of arylamines BASF AKTIENGESELLSCHAFT (DT) 1978-01-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170036200-A1 1-HEXENE PRODUCTION PROCESS AP1M1, HK1, CYC1 ALDH1A1 1321/4885HPGD 1006/4885TSHR 1183/4885
US-20120184431-A1 TRANSITION METAL COMPLEX, PREPARATION METHOD FOR SAID TRANSITION METAL COMPLEX, TRIMERIZATION CATALYST, PREPARATION METHOD FOR 1-HEXENE, PREPARATION METHOD FOR ETHYLENE POLYMER, SUBSTITUTED CYCLOPENTADIENE COMPOUND, AND PREPARATION METHOD FOR SAID SUBSTITUTED CYCLOPENTADIENE COMPOUND EMC1, CYC1, AP1M1 ALDH1A1 2139/4885HPGD 778/4885TSHR 2248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback